Thyroid dysfunction in patients with advanced renal cell carcinoma treated with sunitinib: A multifactorial issue;Disfunción tiroidea en los pacientes con carcinoma de células renales avanzado en tratamiento con sunitinib: Un problema multifactorial

Endocrinologia y Nutricion

Volumn 57, Issue 10, 2010, Pages 486-491

  Fuertes Zamorano Nuria, N ^a   De Miguel Novoa, María Paz ^a   Molino González, Ángel ^a   Díaz Pérez, José Ángel ^a   Rojas Marcos, Patricia Martín ^a   Montañez Zorrilla, María Carmen ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Euthyroid sick syndrome; Glucocorticoids; Hypothyroidism; Protein kinase inhibitors; Renal cell carcinoma; Sunitinib; Thyroid function tests; Thyroid hormones; Thyrotropin

Indexed keywords

LIOTHYRONINE; SUNITINIB; THYROTROPIN; THYROXINE;

ADULT; ADVANCED CANCER; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; KIDNEY CARCINOMA; MALE; PATIENT MONITORING; PREVALENCE; RETROSPECTIVE STUDY; THYROID DISEASE; THYROID FUNCTION; TREATMENT DURATION;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; HUMANS; HYPOTHYROIDISM; INDOLES; KIDNEY NEOPLASMS; MIDDLE AGED; PREVALENCE; PROTEIN KINASE INHIBITORS; PYRROLES; RETROSPECTIVE STUDIES; THYROID HORMONES; THYROTROPIN;

EID: 78649876888     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2010.06.002     Document Type: Article

References (18)

1. Illouz F., Laboureau-Soares S., Dubois S., Rohmer V., Rodien P. Tyrosine kinase inhibitors and modifications of thyroid function tests: a review. Eur J Endocrinol 2009, 160:331-336.
2. Desai J., Yassa L., Marqusse E., George S., Frates M.C., Chen M.H., et al. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med 2006, 145:660-664.
3. Wong E., Rosen L.S., Mulay M., Vanvugt A., Dinolfo M., Tomoda C., et al. Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity. Thyroid 2007, 17:351-355.
4. Rini B.I., Tamaskar I., Shaheen P., Salas R., García J., Wood L., et al. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst 2007, 99:81-83.
5. Mannavola D., Coco P., Vannucchi G., Bertuelli R., Carletto M., Casali P.G., et al. A novel tyrosine-kynase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. J Clin Endocrinol Metab 2007, 92:3531-3534.
6. Wolter P., Stefan C., Decallone B., Dumez H., Bex M., Carmeliet P., et al. The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation. Br J Cancer 2008, 99:448-454.
7. Grossmann M., Premaratne E., Desait J., Davis D. Thyrotoxicosis during sunitinib treatment for renal cell carcinoma. Clin Endocrinol (Oxf) 2008, 69:669-672.
8. Kamba T., Tam B.Y., Hashizume H., Haskell A., Sennino B., Mancuso M.R., et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 2006, 290:560-576.
9. De Groot J.W., Links T.P., van der Graaf W.T. Tyrosine kinase inhibitors causing hypothyroidism in a patient on levothyroxine. Ann Oncol 2006, 17:1719-1720.
10. De Groot J.W., Zonnenberg B.A., Plukker J.T., van der Graaf W.T., Links T.P. Imatinib induces hypothyroidism in patients receiving levothyroxine. Clin Pharmacol Ther 2005, 78:433-438.
11. Chopra I.J. Euthyroid sick syndrome: Is it a misnomer?. J Clin Endocrinol Metab 1997, 82:329-334.
12. Utiger R.D. Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat?. N Engl J Med 1995, 333:1562-1563.
13. Garfield D., Hercbergs A., Davis P. Unaswered questions regarding the management of sunitinib-induced hypothyroidism. Nat Clin Pract Oncol 2007, 4:674.
14. Davis P.J., Davis F.B., Lin H.Y., Bergh J.J., Mousa S., Hercbergs A., et al. Cell surface receptor for thyroid hormone and tumor cell proliferation. Expert Rev Endocrinol Metab 2006, 1:753-761.
15. Nelson M., Hercbergs A., Rybicki L., Strome M. Association between development of hypothyroidism and improved survival in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1999, 132:1041-1046.
16. Porlan E., Vega S., Iglesias T., Rodríguez-Peña A. Unliganded thyroid hormone receptor beta1 inhibits proliferation of murine fibroblasts by delaying the onset of the G1 cell-cycle signals. Oncogene 2004, 23:8756-8765.
17. Porlan E., Vidaurre O.G., Rodríguez-Peña A. Thyroid hormone receptor-Β (TRΒ1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2. Oncogene 2008, 27:2795-2800.
18. Wolter P., Stefan C., Decallone B., Dumez H., Fieuws S., Clement P., et al. Evaluation of thyroid dysfunction as a candidate surrogate marker for efficacy of sunitinib in patients with advanced renal cell cancer. J Clin Oncol 2008, 26(15S):5126.